Oncology Learning Network

Podcast by HMP Global

Oncology Learning Network is a health podcast hosted by Unknown Host, with 187 episodes on record and a Required Pod Score of 80. PitchCentric scores this show on Booking Probability, Listen Score, and live audience signals refreshed every 24 hours.

Unknown Host hosts Oncology Learning Network, a health show with 187 episodes published.

Our AI reads these to draft pitches. Use them as grounding for a pitch that cites a real guest and a specific topic.

• 

  Oncology Learning Network

  Preparing for Biomarker-Directed Care in epNEC: What Pathologists Need to Know Now

  Aug 26, 202612 min

  This podcast features Dr David Klimstra discussing how pathologists can prepare for biomarker-directed care in extrapulmonary neuroendocrine carcinoma (epNEC). Key topics include accurate NEC classification before delta-like ligand 3 (DLL3) assessment, tissue stewardship, timing and location of immunohistochemistry testing, evolving scoring thresholds, and the importance of close pathology-oncology communication to support treatment decisions and emerging DLL3-directed strategies.

  ListenShow Notes
• 

  Oncology Learning Network

  Artificial Intelligence for Skin Cancer Diagnosis

  Aug 4, 202612 min

  Luc Thomas, MD, PhD, discusses findings from a real-world study comparing artificial intelligence models with clinicians for skin cancer diagnosis, highlighting the strengths and limitations of artificial intelligence and reinforcing the continued importance of physician expertise in dermoscopy and melanoma detection.

  ListenShow Notes
• 

  Oncology Learning Network

  Testing Matters: Practical Approaches to Biomarker Evaluation in NSCLC

  Jul 14, 20267 min

  Dr Jamie Chaft reviews the importance of early tissue stewardship in NSCLC, including how biopsy planning, tissue adequacy, and coordination across the care team can influence biomarker testing and treatment planning. The discussion emphasizes practical strategies to support current and future molecular testing needs.

  ListenShow Notes
• 

  Oncology Learning Network

  Real-World Decision Points in Biomarker-Driven NSCLC Management

  Jul 14, 20265 min

  Dr Jamie Chaft discusses how longitudinal biomarker assessment can support treatment planning, resistance evaluation, and rebiopsy decision-making in NSCLC. Key topics include disease progression, tissue limitations, prior assay results, multidisciplinary collaboration, and individualized testing strategies.

  ListenShow Notes
• 

  Oncology Learning Network

  Beyond FVC: What FIBRONEER-ILD Means for Outcomes, Patients, and Access in PPF

  Jul 14, 202617 min

  In this expert commentary, Toby Maher, MD, PhD, discusses the evolving treatment landscape in progressive pulmonary fibrosis (PPF) and the potential implications of the longer-term FIBRONEER-ILD trial findings. He explores how nerandomilast may address key unmet needs in PPF, with a focus on disease progression, clinically meaningful outcomes, treatment sequencing, and the broader impact on patients, providers, and health care systems.

  ListenShow Notes

Based on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:

Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.